Skip to main content

Registrational Study With Omecamtiv Mecarbil (AMG 423) to Treat Chronic Heart Failure With Reduced Ejection Fraction

Submitted by Anonymous (not verified) on Tue, 07/19/2022 - 15:18
  • Read more about Registrational Study With Omecamtiv Mecarbil (AMG 423) to Treat Chronic Heart Failure With Reduced Ejection Fraction

A Safety and Efficacy Study of a Bowel Cleansing Preparation (BLI800) in Pediatric Subjects Undergoing Colonoscopy

Submitted by Anonymous (not verified) on Tue, 07/19/2022 - 15:18
  • Read more about A Safety and Efficacy Study of a Bowel Cleansing Preparation (BLI800) in Pediatric Subjects Undergoing Colonoscopy

Efficacy and Safety of LCZ696 Compared to Valsartan on Cognitive Function in Patients With Chronic Heart Failure and Preserved Ejection Fraction

Submitted by Anonymous (not verified) on Tue, 07/19/2022 - 15:18
  • Read more about Efficacy and Safety of LCZ696 Compared to Valsartan on Cognitive Function in Patients With Chronic Heart Failure and Preserved Ejection Fraction

Prevention of Non-Surgical Bleeding by Management of HeartMate II Patients Without Antiplatelet Therapy

Submitted by Anonymous (not verified) on Tue, 07/19/2022 - 15:18
  • Read more about Prevention of Non-Surgical Bleeding by Management of HeartMate II Patients Without Antiplatelet Therapy

Long-term Study of Teduglutide in Pediatric Subjects With Short Bowel Syndrome Who Completed the TED-C13-003 Study

Submitted by Anonymous (not verified) on Tue, 07/19/2022 - 15:18
  • Read more about Long-term Study of Teduglutide in Pediatric Subjects With Short Bowel Syndrome Who Completed the TED-C13-003 Study

Zenith TX2® Post-market Approval Study

Submitted by Anonymous (not verified) on Tue, 07/19/2022 - 15:18
  • Read more about Zenith TX2® Post-market Approval Study

Anemia Studies in Chronic Kidney Disease: Erythropoiesis Via a Novel Prolyl Hydroxylase Inhibitor Daprodustat-Dialysis (ASCEND-D)

Submitted by Anonymous (not verified) on Tue, 07/19/2022 - 15:18
  • Read more about Anemia Studies in Chronic Kidney Disease: Erythropoiesis Via a Novel Prolyl Hydroxylase Inhibitor Daprodustat-Dialysis (ASCEND-D)

The HeartWare™ Ventricular Assist System as Destination Therapy of Advanced Heart Failure: the ENDURANCE Trial

Submitted by Anonymous (not verified) on Tue, 07/19/2022 - 15:18
  • Read more about The HeartWare™ Ventricular Assist System as Destination Therapy of Advanced Heart Failure: the ENDURANCE Trial

Study of ALXN1210 in Complement Inhibitor Treatment-Naïve Adult and Adolescent Participants With Atypical Hemolytic Uremic Syndrome (aHUS)

Submitted by Anonymous (not verified) on Tue, 07/19/2022 - 15:18
  • Read more about Study of ALXN1210 in Complement Inhibitor Treatment-Naïve Adult and Adolescent Participants With Atypical Hemolytic Uremic Syndrome (aHUS)

Treatments Against RA and Effect on FDG-PET/CT

Submitted by Anonymous (not verified) on Tue, 07/19/2022 - 15:18
  • Read more about Treatments Against RA and Effect on FDG-PET/CT

Pagination

  • First page First
  • Previous page Previous
  • …
  • Page 126
  • Page 127
  • Page 128
  • Page 129
  • Page 130
  • Page 131
  • Page 132
  • Page 133
  • Page 134
  • …
  • Next page Next
  • Last page Last
Subscribe to